Techbankmed

Shanghai, China Founded: 2017 • Age: 9 yrs
Auxiliary medical devices for cardiac interventional surgery are manufactured.
Annual revenue - Latest available
Total funding $14.9M 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Techbankmed

Techbankmed is a company based in Shanghai (China) founded in 2017. Techbankmed has raised $14.93 million across 1 funding round from investors including Puhua Capital. Techbankmed offers products and services including SAFER Esophageal Retractor and Cardiovascular Innovation Services.

Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $14.93 M (USD)

    in 1 rounds

  • Latest Funding Round
    $14.93 M (USD), Series B

    Jul 05, 2022

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Techbankmed

Techbankmed offers a comprehensive portfolio of products and services, including SAFER Esophageal Retractor and Cardiovascular Innovation Services.

Product name locked
Category locked
Primary

This device is used for esophageal retraction in medical procedures and was approved under special review processes.

Product name locked
Category locked
Locked

Services for developing and commercializing cardiovascular technologies are provided through partnerships and intellectual property management.

Funding Insights of Techbankmed

Techbankmed has successfully raised a total of $14.93M through 1 strategic funding round. The most recent funding activity was a Series B round of $14.93 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Techbankmed

Techbankmed has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Puhua Capital.

All
Venture Fund
Investor Description Founded Year Domain Location
Health and technology startups are invested in by Puhua Capital.
Locked Locked Locked
Premium access

Investor details for Techbankmed

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Techbankmed

Investments
Premium access

Investment portfolio details for Techbankmed

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Techbankmed

Premium access

Detailed financials for Techbankmed

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Techbankmed Comparisons

Techbankmed Primary company
Description
Auxiliary medical devices for cardiac interventional surgery...
Location
Shanghai, China
Founded Year
2017
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Techbankmed

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Techbankmed

Premium access

Detailed competitors of Techbankmed

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Techbankmed

Premium access

Complete news archive for Techbankmed

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Techbankmed

Techbankmed was founded in 2017 and raised its 1st funding round 5 years after it was founded.

Techbankmed is headquartered in Shanghai, China.

Techbankmed is a funded company, having raised a total of $14.93M across 1 funding round to date.

Techbankmed was established in 2017 in Shanghai, China, as a manufacturer within the medical devices sector. Auxiliary devices designed for cardiac interventional surgery are produced, supporting procedures in healthcare settings. Operations are centered on development and production of these specialized tools, with a focus on the interventional cardiology field. The company serves markets through its domain, techbankmed.com, based in the Asia-Pacific region.

Techbankmed offers SAFER Esophageal Retractor and Cardiovascular Innovation Services.

Techbankmed has 1 investor. Key investors include Puhua Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available